No Data
Selected announcements | CHINAHONGQIAO expects annual Net income to nearly double year-on-year; GOLDLION HOLD receives a premium for privatization, resuming trading today.
CHINAHONGQIAO expects that the Net income for the year ending December 31, 2024, may increase by around 95% year-on-year; China Coal Energy's Commodity coal sales for the first 11 months were 0.256 billion tons, showing a decrease of 1.9% year-on-year; November sales were 25.8 million tons, representing a year-on-year increase of 11.4%.
CH BIOTECH SER (08037.HK) plans to issue 6 million US dollars in convertible Bonds.
Gelonghui, December 17 | CH BIOTECH SER (08037.HK) announced that on December 17, 2024, the company entered into a subscription agreement with the subscriber, whereby the subscriber has conditionally agreed to subscribe for convertible Bonds with a total principal amount of 6 million US dollars.
Express News | China Biotech Services Holdings Ltd - Issue of Convertible Bonds of US$6 Mln
Express News | China Biotech Services - Agricultural Bank of China Limited Qionghai Sub-Branch to Provide Loan in Principal Amount of RMB50 Mln to Unit
Hong Kong stock announcement | Goldensolar plans to join hands with Juhua Energy and Longi Green Energy Technology to establish a joint venture company to produce HBC solar batteries.
Dingqiao Communication and China Soft International have signed a cooperation agreement to jointly start a new chapter of domestic cooperation...
Ch Biotech Ser (08037.HK) plans to cooperate with Jinshazhou Hospital of Guangzhou University of Traditional Chinese Medicine in the fields such as boron neutron capture therapy pharmaceuticals and medical instruments, referral cooperation, equity coopera
On September 19, 2024, Ch Biotech Ser (08037.HK) announced that on September 19, 2024, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. ("Pengbo (Hainan)") (a wholly-owned subsidiary indirectly owned by the company) entered into a cooperation framework intention letter with Jinshazhou Hospital of Guangzhou University of Traditional Chinese Medicine ("the hospital"). The main areas of cooperation include boron neutron capture therapy (BNCT) treatment drugs and medical instruments, referral cooperation, equity cooperation, and indication expansion. The hospital is approved by the Guangzhou Health Commission and is a medical institution that integrates medical
Some China Biotech Services Holdings Limited (HKG:8037) Shareholders Look For Exit As Shares Take 30% Pounding
